Sfoglia per Rivista VACCINES
Pneumococcal disease prevention: Arewe on the right track?
2021-01-01 Principi, N.; Esposito, S.
Prevention of congenital cytomegalovirus infection with vaccines: State of the art
2021-01-01 Esposito, S.; Chiopris, G.; Messina, G.; D'Alvano, T.; Perrone, S.; Principi, N.
Protective MVA-ST Vaccination Robustly Activates T Cells and Antibodies in an Aged-Hamster Model for COVID-19
2024-01-01 Clever, S; Schünemann, Lm; Armando, F; Natrup, Cmz; Tuchel, T; Tscherne, A; Ciurkiewicz, M; Baumgärtner, W; Sutter, G; Volz, A
Sars-cov-2 neutralizing antibodies: A network meta-analysis across vaccines
2021-01-01 Rogliani, P.; Chetta, A.; Cazzola, M.; Calzetta, L.
A simplified sars-cov-2 pseudovirus neutralization assay
2021-01-01 Donofrio, G.; Franceschi, V.; Macchi, F.; Russo, L.; Rocci, A.; Marchica, V.; Costa, F.; Giuliani, N.; Ferrari, C.; Missale, G.
Vaccinating Front-Line Healthcare Workers: Results of a Pre-Pandemic Cross-Sectional Study from North-Eastern Italy on First Responders
2022-01-01 Ricco, M.; Vezzosi, L.; Marchesi, F.
Vaccination against paediatric respiratory pathogens
2019-01-01 Bianchini, S.; Argentiero, A.; Camilloni, B.; Silvestri, E.; Alunno, A.; Esposito, S.
Vaccines against coronaviruses: The state of the art
2020-01-01 Conte, C.; Sogni, F.; Affanni, P.; Veronesi, L.; Argentiero, A.; Esposito, S.
Vaccines in children with inflammatory bowel disease: Brief review
2021-01-01 Esposito, S.; Antoniol, G.; Labate, M.; Passadore, L.; Alvisi, P.; Dacco, V.; Ghizzi, C.; Colombo, C.; Principi, N.
Why it is important to develop an effective and safe pediatric COVID-19 vaccine
2021-01-01 Principi, N.; Esposito, S.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Pneumococcal disease prevention: Arewe on the right track? | 1-gen-2021 | Principi, N.; Esposito, S. | |
Prevention of congenital cytomegalovirus infection with vaccines: State of the art | 1-gen-2021 | Esposito, S.; Chiopris, G.; Messina, G.; D'Alvano, T.; Perrone, S.; Principi, N. | |
Protective MVA-ST Vaccination Robustly Activates T Cells and Antibodies in an Aged-Hamster Model for COVID-19 | 1-gen-2024 | Clever, S; Schünemann, Lm; Armando, F; Natrup, Cmz; Tuchel, T; Tscherne, A; Ciurkiewicz, M; Baumgärtner, W; Sutter, G; Volz, A | |
Sars-cov-2 neutralizing antibodies: A network meta-analysis across vaccines | 1-gen-2021 | Rogliani, P.; Chetta, A.; Cazzola, M.; Calzetta, L. | |
A simplified sars-cov-2 pseudovirus neutralization assay | 1-gen-2021 | Donofrio, G.; Franceschi, V.; Macchi, F.; Russo, L.; Rocci, A.; Marchica, V.; Costa, F.; Giuliani, N.; Ferrari, C.; Missale, G. | |
Vaccinating Front-Line Healthcare Workers: Results of a Pre-Pandemic Cross-Sectional Study from North-Eastern Italy on First Responders | 1-gen-2022 | Ricco, M.; Vezzosi, L.; Marchesi, F. | |
Vaccination against paediatric respiratory pathogens | 1-gen-2019 | Bianchini, S.; Argentiero, A.; Camilloni, B.; Silvestri, E.; Alunno, A.; Esposito, S. | |
Vaccines against coronaviruses: The state of the art | 1-gen-2020 | Conte, C.; Sogni, F.; Affanni, P.; Veronesi, L.; Argentiero, A.; Esposito, S. | |
Vaccines in children with inflammatory bowel disease: Brief review | 1-gen-2021 | Esposito, S.; Antoniol, G.; Labate, M.; Passadore, L.; Alvisi, P.; Dacco, V.; Ghizzi, C.; Colombo, C.; Principi, N. | |
Why it is important to develop an effective and safe pediatric COVID-19 vaccine | 1-gen-2021 | Principi, N.; Esposito, S. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile